Jane Street’s Corbus Pharmaceuticals CRBP Stock Holding History

Jane Street’s Portfolio CRBP Stock Details CRBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$269K	Buy	+28,600	New	+$241K	﹤0.01%	9477
2025 Q1	–	Sell	-448,600	Closed	-$5.29M	–	9574
2024 Q4	$5.29M	Buy	448,600 +317,600	+242%	+$5.33M	﹤0.01%	2587
2024 Q3	$2.7M	Buy	+131,000	New	+$6.7M	﹤0.01%	3904
2022 Q1	–	Sell	-1,037	Closed	-$19K	–	10369
2021 Q4	$19K	Sell	1,037 -123	-11%	-$3.33K	﹤0.01%	9804
2021 Q3	$35K	Sell	1,160 -2,540	-69%	-$100K	﹤0.01%	9641
2021 Q2	$203K	Sell	3,700 -920	-20%	-$51.1K	﹤0.01%	8798
2021 Q1	$273K	Sell	4,620 -2,567	-36%	-$169K	﹤0.01%	7826
2020 Q4	$270K	Sell	7,187 -20,526	-74%	-$767K	﹤0.01%	6557
2020 Q3	$1.5M	Buy	27,713 +22,373	+419%	+$4.05M	﹤0.01%	3459
2020 Q2	$1.34M	Buy	+5,340	New	+$1.08M	﹤0.01%	3642

Other funds holding CRBP

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jane Street's CRBP Position: Q1 2026 in Review

Jane Street increased its Corbus Pharmaceuticals (CRBP) stake by 161% in Q1 2026, buying an estimated $380K and bringing the position to 73,193 shares worth $687K. The position accounts for ﹤0.01% of the portfolio, ranked #7309.

Jane Street first reported a position in CRBP in Q3 2016 and has held it in 21 quarters since. The position peaked at $1.27M in Q1 2024. 107 funds tracked by Wall St. Rank hold CRBP as of Q1 2026.

Jane Street held 73,193 shares of Corbus Pharmaceuticals worth $687K as of Q1 2026.
Jane Street bought 45,129 Corbus Pharmaceuticals shares in Q1 2026, an estimated $380K.
Corbus Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #7309 holding.
Jane Street first reported a position in Corbus Pharmaceuticals in Q3 2016 and has held it in 21 quarters since.
Jane Street's Corbus Pharmaceuticals position peaked at $1.27M in Q1 2024.
107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.